FC
CRL icon

FORA Capital’s Charles River Laboratories CRL Stock Holding History

FORA Capital’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,337
Closed -$366K – 478
2025
Q3 		$366K Buy
+2,337
New +$371K 0.06% 339
2025
Q2 		– Sell
-2,093
Closed -$315K – 538
2025
Q1 		$315K Sell
2,093
-6,967
-77% -$1.17M 0.03% 393
2024
Q4 		$1.67M Buy
9,060
+3,034
+50% +$584K 0.19% 158
2024
Q3 		$1.19M Sell
6,026
-2,961
-33% -$615K 0.14% 191
2024
Q2 		$1.86M Buy
+8,987
New +$2.04M 0.23% 143
2023
Q2 		– Sell
-8,143
Closed -$1.64M – 400
2023
Q1 		$1.64M Buy
+8,143
New +$1.85M 0.16% 179
2022
Q3 		– Sell
-4,166
Closed -$891K – 439
2022
Q2 		$891K Sell
4,166
-2,338
-36% -$571K 0.18% 165
2022
Q1 		$1.89M Buy
+6,504
New +$2.01M 0.34% 79
2021
Q2 		– Sell
-718
Closed -$208K – 919
2021
Q1 		$208K Sell
718
-687
-49% -$191K 0.07% 278
2020
Q4 		$351K Buy
+1,405
New +$335K 0.05% 368
2020
Q3 		– Sell
-2,447
Closed -$427K – 708
2020
Q2 		$427K Buy
2,447
+1,656
+209% +$264K 0.15% 182
2020
Q1 		$100K Buy
791
+348
+79% +$52.2K 0.02% 612
2019
Q4 		$68K Buy
+443
New +$61.3K 0.01% 838

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

FORA Capital's CRL Position: Q4 2025 in Review

FORA Capital sold out of Charles River Laboratories (CRL) in Q4 2025, closing a stake of 2,337 shares — an estimated $366K sold.

FORA Capital first reported a position in CRL in Q4 2019 and held it in 13 quarters. The position peaked at $1.89M in Q1 2022. 580 funds tracked by Wall St. Rank hold CRL as of Q4 2025.

  • FORA Capital reported no remaining Charles River Laboratories position as of Q4 2025 after selling out during the quarter.
  • FORA Capital sold 2,337 Charles River Laboratories shares in Q4 2025, an estimated $366K.
  • FORA Capital first reported a position in Charles River Laboratories in Q4 2019 and held it in 13 quarters.
  • FORA Capital's Charles River Laboratories position peaked at $1.89M in Q1 2022.
  • 580 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2025.

Based on FORA Capital's 13F filing for Q4 2025, filed 13 Feb 2026.